PATENT CLAIM ANALYSIS

Application Number: 16225920
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-05
Patent Classification: ["514", "210200"]

Abstract:
The present invention relates to compounds of formula (I): or pharmaceutically acceptable salts thereof, as well as processes for their manufacture, pharmaceutical compositions comprising them, and their use as medicaments.

Claim (Index 20):
The compound of  claim 1 , wherein each R 5  is independently selected from hydroxy, C 1-7  alkoxy, NR 12 R 13 , COR 9 , CONR 10 R 11 , SO 2 \u2014C 1-7  alkyl, SO 2 \u2014NR 10 R 11 , heterocycloalkyl and heteroaryl;\n wherein C 1-7  alkoxy is optionally substituted by COR 9  or CONR 10 R 11 ; wherein heterocycloalkyl and heteroaryl are optionally substituted with one or two substituents selected from halo, C 1-7  alkyl, halo-C 1-7  alkyl, hydroxy, C 1-7  alkoxy, oxo, COR 9 , C 1-7  alkyl-COR 9  and NR 10 R 11 .

Metadata:
- Claim Count in Document: 99.0
- Percentile: 98.0
- Lexical Diversity: 1.15625
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12845045', '14458062', '13272079', '13519872', '12815800']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7651703173066178
- 35 USC 102 Novelty (BERT): 0.5124361805075431
- Combined Prediction Score: 0.7398969036267103
- Mean Citation Score: 282.042748
- Max Citation Score: 286.458
- Similarity Product: 233.02365918588643

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test